[HTML][HTML] Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks

A Peixoto, M Relvas-Santos, R Azevedo… - Frontiers in …, 2019 - frontiersin.org
Decades of research have disclosed a plethora of alterations in protein glycosylation that
decisively impact in all stages of disease and ultimately contribute to more aggressive cell …

[HTML][HTML] The distinct roles of sialyltransferases in cancer biology and onco-immunology

M Hugonnet, P Singh, Q Haas… - Frontiers in …, 2021 - frontiersin.org
Aberrant glycosylation is a key feature of malignant transformation. Hypersialylation, the
enhanced expression of sialic acid-terminated glycoconjugates on the cell surface, has …

[HTML][HTML] Aberrant sialylation in cancer: biomarker and potential target for therapeutic intervention?

S Pietrobono, B Stecca - Cancers, 2021 - mdpi.com
Simple Summary Sialylation is a post-translational modification that consists in the addition
of sialic acid to growing glycan chains on glycoproteins and glycolipids. Aberrant sialylation …

Sialylation is involved in cell fate decision during development, reprogramming and cancer progression

F Li, J Ding - Protein & cell, 2019 - academic.oup.com
Sialylation, or the covalent addition of sialic acid to the terminal end of glycoproteins, is a
biologically important modification that is involved in embryonic development …

[HTML][HTML] Recent advances in the development of sialyltransferase inhibitors to control cancer metastasis: A comprehensive review

R Al Saoud, A Hamrouni, A Idris, WK Mousa… - Biomedicine & …, 2023 - Elsevier
Metastasis accounts for the majority of cancer-associated mortalities, representing a huge
health and economic burden. One of the mechanisms that enables metastasis is …

[HTML][HTML] Serum sialylation changes in cancer

Z Zhang, M Wuhrer, S Holst - Glycoconjugate journal, 2018 - Springer
Cancer is a major cause of death in both developing and developed countries. Early
detection and efficient therapy can greatly enhance survival. Aberrant glycosylation has …

O-glycan recognition and function in mice and human cancers

GE Cervoni, JJ Cheng, KA Stackhouse… - Biochemical …, 2020 - portlandpress.com
Protein glycosylation represents a nearly ubiquitous post-translational modification, and
altered glycosylation can result in clinically significant pathological consequences. Here we …

[HTML][HTML] Sialic acid metabolism: a key player in breast cancer metastasis revealed by metabolomics

ST Teoh, MP Ogrodzinski, C Ross, KW Hunter… - Frontiers in …, 2018 - frontiersin.org
Metastatic breast cancer is currently incurable. It has recently emerged that different
metabolic pathways support metastatic breast cancer. To further uncover metabolic …

[HTML][HTML] ST3 beta-galactoside alpha-2, 3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer

R Garnham, D Geh, R Nelson, E Ramon-Gil… - Communications …, 2024 - nature.com
Immune checkpoint blockade has yet to produce robust anti-cancer responses for prostate
cancer. Sialyltransferases have been shown across several solid tumours, including breast …

The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins

F Jin, F Wang - Glycoconjugate Journal, 2020 - Springer
In the past decades, the roles of carbohydrates in living organisms and their potential use in
many fields have been extensively investigated. Sialyl Lewis x (sLe x), a member of body …